Skip to main content

Amlexanox for the Treatment of Recurrent Aphthous Ulcers

Clinical Drug Investigation volume 25, pages 555–566 (2005)Cite this article

Abstract

Recurrent aphthous ulcer (RAU) is the most prevalent oral mucosal disease in humans, estimated to affect between 5% and 50% of the general population. The minor manifestation of the condition is the most common and is characterised by small, shallow, round or oval lesions that are surrounded by a raised erythematous halo and are covered by a grey-white pseudomembrane. Appropriate management of patients with this condition is largely symptomatic and should focus on reducing ulcer duration, relieving pain and reducing or preventing ulcer recurrence. Amlexanox is a novel anti-inflammatory and anti-allergic agent that has been evaluated for the treatment of RAU in a series of robust clinical trials. After a 100mg dose of 5% amlexanox topical paste, applied directly to the lesion, the maximum serum concentration of the drug was 120 ng/mL, which was achieved 2.4 hours after application. Steady-state concentrations were achieved within 1 week of starting four times daily dosing and there was no evidence of accumulation. In terms of efficacy, application of 5% amlexanox topical paste was shown to consistently and significantly accelerate complete ulcer healing and the time to resolution of pain across four large efficacy studies. Significantly more patients had completely healed ulcers from day 3 (compared with no treatment) and day 4 (compared with vehicle). Healing was mirrored by an improvement in pain: significantly more patients had complete resolution of pain from day 2 (compared with no treatment) and day 3 (compared with vehicle). Overall, amlexanox was well tolerated, with a low frequency of adverse effects. In the oral application studies, adverse effects that were considered by investigators to be potentially related to the study treatment occurred in 2.4% and 2.1% of 5% amlexanox and vehicle recipients, respectively. These effects were mainly local and were all classed as mild to moderate in severity, with the exception of one case of severe stinging in the vehicle treatment group. Furthermore, the incidence of dermal irritation and sensitisation was very low with amlexanox. These findings suggest that 5% amlexanox topical paste is a useful and well tolerated therapeutic option for the treatment of RAU.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 49.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Table I
Table II
Table III
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Table IV

References

  1. Rogers III RS. Recurrent aphthous stomatitis: clinical characteristics and associated systemic disorders. Semin Cutan Med Surg 1997; 16(4): 278–83

    Article  PubMed  Google Scholar 

  2. Ship II. Epidemiologic aspects of recurrent aphthous ulcerations. Oral Surg Oral Med Oral Pathol 1972; 33(3): 400–6

    Article  PubMed  CAS  Google Scholar 

  3. Shulman JD. An exploration of point, annual, and lifetime prevalence in characterizing recurrent aphthous stomatitis in USA children and youths. J Oral Pathol Med 2004; 33(9): 558–66

    Article  PubMed  Google Scholar 

  4. Ship JA. Recurrent aphthous stomatitis: an update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 81(2): 141–7

    Article  PubMed  CAS  Google Scholar 

  5. Field EA, Brookes V, Tyldesley WR. Recurrent aphthous ulceration in children: a review. Int J Paediatr Dent 1992; 2(l): l–10

    Google Scholar 

  6. Cooke BE. Recurrent oral ulceration. Br J Dermatol 1969; 81(2): 159–61

    PubMed  CAS  Google Scholar 

  7. Lehner T. Autoimmunity in oral diseases, with special reference to recurrent oral ulceration. Proc R Soc Med 1968; 61(5): 515–24

    PubMed  CAS  Google Scholar 

  8. Rennie JS, Reade PC, Hay KD, et al. Recurrent aphthous stomatitis. Br Dent J 1985; 159(11): 361–7

    Article  PubMed  CAS  Google Scholar 

  9. Akintoye SO, Greenberg MS. Recurrent aphthous stomatitis. Dent Clin North Am 2005; 49(1): 31–47, vii-viii

    Article  PubMed  Google Scholar 

  10. Greenberg MS, Pinto A. Etiology and management of recurrent aphthous stomatitis. Curr Infect Dis Rep 2003; 5(3): 194–8

    Article  PubMed  Google Scholar 

  11. Stanley HR. Aphthous lesions. Oral Surg Oral Med Oral Pathol 1972; 33(3): 407–16

    Article  PubMed  CAS  Google Scholar 

  12. Jorizzo JL, Taylor RS, Schmalstieg FC, et al. Complex aphthosis: a forme fruste of Behcet’s syndrome? J Am Acad Dermatol 1985; 13(1): 80–4

    Article  PubMed  CAS  Google Scholar 

  13. Landesberg R, Fallon M, Insel R. Alterations of T helper/ inducer and T suppressor/inducer cells in patients with recurrent aphthous ulcers. Oral Surg Oral Med Oral Pathol 1990; 69(2): 205–8

    Article  PubMed  CAS  Google Scholar 

  14. Pedersen A, Hougen HP, Kenrad B. T-lymphocyte subsets in oral mucosa of patients with recurrent aphthous ulceration. J Oral Pathol Med 1992; 21(4): 176–80

    Article  PubMed  CAS  Google Scholar 

  15. Greenspan JS, Gadol N, Olson JA, et al. Antibody-dependent cellular cytotoxicity in recurrent aphthous ulceration. Clin Exp Immunol 1981; 44(3): 603–10

    PubMed  CAS  Google Scholar 

  16. Greenspan JS, Gadol N, Olson JA, et al. Lymphocyte function in recurrent aphthous ulceration. J Oral Pathol 1985; 14(8): 592–602

    Article  PubMed  CAS  Google Scholar 

  17. Porter SR, Scully C, Pedersen A. Recurrent aphthous stomatitis. Crit Rev Oral Biol Med 1998; 9(3): 306–21

    Article  PubMed  CAS  Google Scholar 

  18. Pedersen A, Hornsleth A. Recurrent aphthous ulceration: a possible clinical manifestation of reactivation of varicella zoster or cytomegalovirus infection. J Oral Pathol Med 1993; 22(2): 64–8

    Article  PubMed  CAS  Google Scholar 

  19. Pedersen A. Recurrent aphthous ulceration: virological and immunological aspects. APMIS Suppl 1993; 37: 1–37

    PubMed  CAS  Google Scholar 

  20. Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc 2003; 134(2): 200–7

    PubMed  Google Scholar 

  21. Ship II. Inheritance of aphthous ulcers of the mouth. J Dent Res 1965; 44(5): 837–44

    Article  PubMed  CAS  Google Scholar 

  22. Woo SB, Sonis ST. Recurrent aphthous ulcers: a review of diagnosis and treatment. J Am Dent Assoc 1996; 127(8): 1202–13

    PubMed  CAS  Google Scholar 

  23. Ferreira M, Davies SL, Butler M, et al. Endomysial antibody: is it the best screening test for coeliac disease? Gut 1992; 33(12): 1633–7

    Article  PubMed  CAS  Google Scholar 

  24. Weusten BL, van de Wiel A. Aphthous ulcers and vitamin B12 deficiency. Neth J Med 1998; 53(4): 172–5

    Article  PubMed  CAS  Google Scholar 

  25. Veloso FT, Saleiro JV. Small-bowel changes in recurrent ulceration of the mouth. Hepatogastroenterology 1987; 34(1): 36–7

    PubMed  CAS  Google Scholar 

  26. Nolan A, Lamey PJ, Milligan KA, et al. Recurrent aphthous ulceration and food sensitivity. J Oral Pathol Med 1991; 20(10): 473–5

    Article  PubMed  CAS  Google Scholar 

  27. Wray D, Graykowski EA, Notkins AL. Role of mucosal injury in initiating recurrent aphthous stomatitis. BMJ (Clin Res Ed) 1981; 283(6306): 1569–70

    Article  CAS  Google Scholar 

  28. Crivelli MR, Aguas S, Adler I, et al. Influence of socioeconomic status on oral mucosa lesion prevalence in schoolchildren. Community Dent Oral Epidemiol 1988; 16(1): 58–60

    Article  PubMed  CAS  Google Scholar 

  29. Sircus W, Church R, Kelleher J. Recurrent aphthous ulceration of the mouth; a study of the natural history, aetiology, and treatment. Q J Med 1957; 26(102): 235–49

    PubMed  CAS  Google Scholar 

  30. Rivera-Hidalgo F, Shulman JD, Beach MM. The association of tobacco and other factors with recurrent aphthous stomatitis in an US adult population. Oral Dis 2004; 10(6): 335–45

    Article  PubMed  CAS  Google Scholar 

  31. Rogers III RS. Recurrent aphthous stomatitis in the diagnosis of Behcet’s disease. Yonsei Med J 1997; 38(6): 370–9

    PubMed  Google Scholar 

  32. Rizzi R, Bruno S, Dammacco R. Behcet’s disease: an immune-mediated vasculitis involving vessels of all sizes. Int J Clin Lab Res 1997; 27(4): 225–32

    Article  PubMed  CAS  Google Scholar 

  33. MacPhail LA, Greenspan D, Greenspan JS. Recurrent aphthous ulcers in association with HIV infection. Diagnosis and treatment. Oral Surg Oral Med Oral Pathol 1992; 73(3): 283–8

    Article  PubMed  CAS  Google Scholar 

  34. MacPhail LA, Greenspan JS. Oral ulceration in HIV infection: investigation and pathogenesis. Oral Dis 1997; 3Suppl. 1: S190–3

    PubMed  Google Scholar 

  35. Feigal DW, Katz MH, Greenspan D, et al. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 1991; 5(5): 519–25

    Article  PubMed  CAS  Google Scholar 

  36. Lamster IB, Begg MD, Mitchell-Lewis D, et al. Oral manifestations of HIV infection in homosexual men and intravenous drug users: study design and relationship of epidemiologic, clinical, and immunologic parameters to oral lesions. Oral Surg Oral Med Oral Pathol 1994; 78(2): 163–74

    Article  PubMed  CAS  Google Scholar 

  37. Rehberger A, Puspok A, Stallmeister T, et al. Crohn’s disease masquerading as aphthous ulcers. Eur J Dermatol 1998; 8(4): 274–6

    PubMed  CAS  Google Scholar 

  38. Delaporte E. Skin manifestions of inflammatory and bowel disease: clinical and therapeutic issues. Res Clin Forums 1998; 20(1): 209–14

    Google Scholar 

  39. Goldstein NS, Gyorfi T. Focal lymphocytic colitis and collagenous colitis: patterns of Crohn’s colitis? Am J Surg Pathol 1999; 23(9): 1075–81

    Article  PubMed  CAS  Google Scholar 

  40. Lisciandrano D, Ranzi T, Carrassi A, et al. Prevalence of oral lesions in inflammatory bowel disease. Am J Gastroenterol 1996; 91(1): 7–10

    PubMed  CAS  Google Scholar 

  41. Ferguson MM, Wray D, Carmichael HA, et al. Coeliac disease associated with recurrent aphthae. Gut 1980; 21(3): 223–6

    Article  PubMed  CAS  Google Scholar 

  42. Lahteenoja H, Toivanen A, Viander M, et al. Oral mucosal changes in coeliac patients on a gluten-free diet. Eur J Oral Sci 1998; 106(5): 899–906

    Article  PubMed  CAS  Google Scholar 

  43. Schibier A, Birrer P, Vella S. PFAPA syndrome: periodic fever, adenitis, pharyngitis and aphthous stomatitis [in German]. Schweiz Med Wochenschr 1997; 127(31-32): 1280–4

    Google Scholar 

  44. Feder Jr HM. Periodic fever, aphthous stomatitis, pharyngitis, adenitis: a clinical review of a new syndrome. Curr Opin Pediatr 2000; 12(3): 253–6

    Article  PubMed  Google Scholar 

  45. Porter SR, Scully C, Standen GR. Autoimmune neutropenia manifesting as recurrent oral ulceration. Oral Surg Oral Med Oral Pathol 1994; 78(2): 178–80

    Article  PubMed  CAS  Google Scholar 

  46. Martinez Montero E, Calero Garcia JL, Moruno Tirado A, et al. Sindrome febril periodico en la infancia debido a sindrome de hiper Ig D. Rev Esp Pediatr 1996; 52(2): 151–74

    Google Scholar 

  47. Ship JA, Chavez EM, Doerr PA, et al. Recurrent aphthous stomatitis. Quintessence Int 2000; 31(2): 95–112

    PubMed  CAS  Google Scholar 

  48. Barrons RW. Treatment strategies for recurrent oral aphthous ulcers. Am J Health Syst Pharm 2001; 58(1): 41–50

    PubMed  CAS  Google Scholar 

  49. Merchant HW, Gangarosa LP, Glassman AB, et al. Betamethasone-17-benzoate in the treatment of recurrent aphthous ulcers. Oral Surg Oral Med Oral Pathol 1978; 45(6): 870–5

    Article  PubMed  CAS  Google Scholar 

  50. Thompson AC, Nolan A, Lamey PJ. Minor aphthous oral ulceration: a double-blind cross-over study of beclomethasone dipropionate aerosol spray. Scott Med J 1989; 34(5): 531–2

    PubMed  CAS  Google Scholar 

  51. Pimlott SJ, Walker DM. A controlled clinical trial of the efficacy of topically applied fluocinonide in the treatment of recurrent aphthous ulceration. Br Dent J 1983; 154(6): 174–7

    Article  PubMed  CAS  Google Scholar 

  52. MacPhee IT, Sircus W, Farmer ED, et al. Use of steroids in treatment of aphthous ulceration. BMJ 1968; 2(598): 147–9

    Article  PubMed  CAS  Google Scholar 

  53. Addy M, Carpenter R, Roberts WR. Management of recurrent aphthous ulceration: a trial of chlorhexidine gluconate gel. Br Dent J 1976; 141(4): 118–20

    Article  PubMed  CAS  Google Scholar 

  54. Hunter L, Addy M. Chlorhexidine gluconate mouthwash in the management of minor aphthous ulceration: a double-blind, placebo-controlled cross-over trial. Br Dent J 1987; 162(3): 106–10

    Article  PubMed  CAS  Google Scholar 

  55. Chadwick B, Addy M, Walker DM. Hexetidine mouthrinse in the management of minor aphthous ulceration and as an adjunct to oral hygiene. Br Dent J 1991; 171(3-4): 83–7

    Article  PubMed  CAS  Google Scholar 

  56. Meiller TF, Kutcher MJ, Overholser CD, et al. Effect of an antimicrobial mouthrinse on recurrent aphthous ulcerations. Oral Surg Oral Med Oral Pathol 1991; 72(4): 425–9

    Article  PubMed  CAS  Google Scholar 

  57. Guggenheimer J, Brightman VJ, Ship II. Effect of chlortetracycline mouthrinses on the healing of recurrent aphthous ulcers: a double-blind controlled trial. J Oral Ther Pharmacol 1968; 4(5): 406–8

    PubMed  CAS  Google Scholar 

  58. Henricsson V, Axell T. Treatment of recurrent aphthous ulcers with Aureomycin mouth rinse or Zendium dentifrice. Acta Odontol Scand 1985; 43(1): 47–52

    Article  PubMed  CAS  Google Scholar 

  59. Graykowski EA, Kingman A. Double-blind trial of tetracycline in recurrent aphthous ulceration. J Oral Pathol 1978; 7(6): 376–82

    Article  PubMed  CAS  Google Scholar 

  60. Lehner T, Wilton JM, Ivanyi L. Double blind crossover trial of levamisole in recurrent aphthous ulceration. Lancet 1976; II(7992): 926–9

    Article  Google Scholar 

  61. De Meyer JD, Degraeve M, Clarysse J, et al. Levamisole in aphthous stomatitis: evaluation of three regimens. BMJ 1977; 1(6062): 671–4

    Article  PubMed  CAS  Google Scholar 

  62. De Cree J, Verhaegen H, De Cock W, et al. A randomized double-blind trial of levamisole in the therapy of recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol 1978; 45(3): 378–84

    Article  PubMed  Google Scholar 

  63. Zissis NP, Hatzioti AJ, Antoniadis D, et al. Therapeutic evaluation of levamisole in recurrent aphthous stomatitis: double-blind comparison of two dosage schedules of levamisole and placebo. J Oral Med 1983; 38(4): 161–3

    PubMed  CAS  Google Scholar 

  64. Olson JA, Silverman Jr S. Double-blind study of levamisole therapy in recurrent aphthous stomatitis. J Oral Pathol 1978; 7(6): 393–9

    Article  PubMed  CAS  Google Scholar 

  65. Miller MF, Silvert ME, Laster LL, et al. Effect of levamisole on the incidence and prevalence of recurrent aphthous stomatitis: a double-blind clinical trial. J Oral Pathol 1978; 7(6): 387–92

    Article  PubMed  CAS  Google Scholar 

  66. Drinnan AJ, Fischman SL. Randomized, double-blind study of levamisole in recurrent aphthous stomatitis. J Oral Pathol 1978; 7(6): 414–7

    Article  PubMed  CAS  Google Scholar 

  67. Jacobson JM, Greenspan JS, Spritzler J, et al. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 1997; 336(21): 1487–93

    Article  PubMed  CAS  Google Scholar 

  68. Jacobson JM, Greenspan JS, Spritzler J, et al. Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers. J Infect Dis 2001; 183(2): 343–6

    Article  PubMed  CAS  Google Scholar 

  69. Grinspan D. Significant response of oral aphthosis to thalidomide treatment. J Am Acad Dermatol 1985; 12 (1 Pt 1): 85–90

    Article  PubMed  CAS  Google Scholar 

  70. Izquierdo C, Isanta C, Guillen A, et al. Recurrent oral aphthosis. Its treatment with colchicine [in Spanish]. Aten Primaria 1989; 6(5): 358–9

    PubMed  CAS  Google Scholar 

  71. Chandrasekhar J, Liem AA, Cox NH, et al. Oxypentifylline in the management of recurrent aphthous oral ulcers: an open clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87(5): 564–7

    Article  PubMed  CAS  Google Scholar 

  72. Wahba-Yahav AV. Pentoxifylline in intractable recurrent aphthous stomatitis: an open trial. J Am Acad Dermatol 1995; 33(4): 680–2

    Article  PubMed  CAS  Google Scholar 

  73. Letsinger JA, McCarty MA, Jorizzo JL. Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide. J Am Acad Dermatol 2005; 52 (3 Pt 1): 500–8

    Article  PubMed  Google Scholar 

  74. Eisen D, Lynch DP. Selecting topical and systemic agents for recurrent aphthous stomatitis. Cutis 2001; 68(3): 201–6

    PubMed  CAS  Google Scholar 

  75. Aphthasol (amlexanox). US Prescribing Information. Available from URL: http://www.rxlist.com [Accessed 2005 Jul]

  76. Saijo T, Kuriki H, Ashida Y, et al. Mechanism of the action of amoxanox (AA-673), an orally active antiallergic agent. Int Arch Allergy Appl Immunol 1985; 78(1): 43–50

    Article  PubMed  CAS  Google Scholar 

  77. Khandwala A, Van Inwegen RG, Alfano MC. 5% amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers: I. clinical demonstration of acceleration of healing and resolution of pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83(2): 222–30

    Article  PubMed  CAS  Google Scholar 

  78. Khandwala A, Van Inwegen RG, Charney MR, et al. 5% amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers: II. pharmacokinetics and demonstration of clinical safety. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83(2): 231–8

    Article  PubMed  CAS  Google Scholar 

  79. Access Pharmaceuticals. Amlexanox for the prevention and treatment of aphthous ulcers. Available from URL: http://www.accesspharma.com/pdf/aphthousulcers.pdf [Accessed 2005 Jul]

  80. Zambon data on file.

Download references

Acknowledgements

This work was supported by an educational grant from Zambon Group. The author was affiliated with Adis International Limited during the preparation of this article. The author has no conflicts of interest to declare.

Author information

Authors and Affiliations

  1. c/o Clinical Drug Investigation, Adis International Limited, Private Bag 65901, Mairangi Bay Auckland, 1311, New Zealand

    Juliette Bell

Authors
  1. Juliette Bell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bell, J. Amlexanox for the Treatment of Recurrent Aphthous Ulcers. Clin. Drug Investig. 25, 555–566 (2005). https://doi.org/10.2165/00044011-200525090-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200525090-00001

Keywords

  • Aphthous Ulcer
  • Recurrent Aphthous Stomatitis
  • Aphthous Stomatitis
  • Ulcer Size
  • Prodromal Stage